Attruby 356 MG tablet 28S
Ended Awarded
- Contract number
- SPE2DB26FY0W8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,778
Award facts
- Contract value 100% obligated
- $12,778.22 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $12,778.22 by the Defense Logistics Agency (DLA) on October 20, 2025, for the supply of Attruby 356 mg tablets (28-count packages). This firm fixed-price delivery order, with an ultimate completion date of November 10, 2025, represents a competitive award with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, PA. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the supply of medications, vaccines, and medical supplies to support military healthcare programs worldwide.
This delivery order supports the Defense Logistics Agency's medical supply chain operations, which procure critical pharmaceuticals and medical commodities for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. AmerisourceBergen's extensive contract portfolio with DLA demonstrates the company's established capability to meet federal procurement requirements through open competition, with previous awards covering a diverse range of therapeutic medications including diabetes treatments, neurological medications, pain management pharmaceuticals, and specialized medical supplies across multiple product categories.
Quick answers
Who was awarded contract SPE2DB26FY0W8?
SPE2DB26FY0W8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 20, 2025.
How much is contract SPE2DB26FY0W8 worth?
The government has obligated $12,778 on SPE2DB26FY0W8.
Is contract SPE2DB26FY0W8 an order under another contract?
Yes. SPE2DB26FY0W8 is a delivery order under SPE2DB20D3303, an indefinite delivery contract.
Was contract SPE2DB26FY0W8 competed?
The extent of competition for SPE2DB26FY0W8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award